Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Evaluation of the Effectiveness of a Community Health Management Program for Dry Eye Disease in Middle-Aged and Elderly Individuals

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

This study evaluates the effectiveness of a community health management program for middle-aged and elderly patients with dry eye disease (DED). By comparing the community-based health management plan with conventional treatment, the study aims to determine the impact on eye health and quality of life.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Patients meeting the diagnostic criteria for dry eye disease. 2. Middle-aged and elderly individuals aged 45 years and above. 3. Normal cognitive and expressive abilities. 4. willing to sign a consent form and ability to complete the survey. 5. Voluntary participation in the study. Who Should NOT Join This Trial: 1. Patients with other ocular surface diseases, including stye, trachoma, allergic conjunctivitis, etc. 2. Patients with severe cataracts, glaucoma, uveitis, retinal detachment, optic nerve diseases, high myopia, or other conditions. 3. Patients who have undergone eye surgery or have a history of eye trauma in the past three months. 4. Patients who did not sign the willing to sign a consent form form. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Patients meeting the diagnostic criteria for dry eye disease. 2. Middle-aged and elderly individuals aged 45 years and above. 3. Normal cognitive and expressive abilities. 4. Informed consent and ability to complete the survey. 5. Voluntary participation in the study. Exclusion Criteria: 1. Patients with other ocular surface diseases, including stye, trachoma, allergic conjunctivitis, etc. 2. Patients with severe cataracts, glaucoma, uveitis, retinal detachment, optic nerve diseases, high myopia, or other conditions. 3. Patients who have undergone eye surgery or have a history of eye trauma in the past three months. 4. Patients who did not sign the informed consent form.

Treatments Being Tested

PROCEDURE

Health Management Intervention Program

This study implemented a 12-week eye health management intervention program based on the Protection Motivation Theory (PMT). The intervention included eye health interventions conducted twice weekly at community health service locations.During the health management process, specialist doctors from higher-level comprehensive hospitals provided professional guidance, while community general practitioners took on a leading role. They provided personalized eye health management for patients under the guidance of the PMT theory. The intervention content included group education, individual guidance, experience sharing meetings, and traditional Chinese medicine appropriate technology, among other aspects.

PROCEDURE

Standard Treatment

Each week, patients were subjected to standard treatment and follow-up procedures, including basic interventions, medication, and routine follow-up via phone or WeChat, during which general conditions were assessed.

Locations (1)

The Third People's Hospital Affiliated to Fujian University of Traditional Chinese Medicine
Fuzhou, Fujian, China